Churchill Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-47,770
Closed -$6.97M 139
2017
Q3
$6.97M Buy
47,770
+2,653
+6% +$361K 0.17% 52
2017
Q2
$5.86M Buy
45,117
+3,921
+10% +$480K 0.15% 58
2017
Q1
$5.13M Buy
41,196
+20,077
+95% +$2.4M 0.15% 60
2016
Q4
$2.44M Sell
21,119
-673
-3% -$74.9K 0.08% 94
2016
Q3
$2.28M Buy
+21,792
New +$2.36M 0.09% 91
2015
Q3
Sell
-15,052
Closed -$1.74M 202
2015
Q2
$1.74M Sell
15,052
-1,135
-7% -$130K 0.06% 128
2015
Q1
$1.87M Buy
+16,187
New +$1.93M 0.06% 123
2014
Q1
Sell
-7,168
Closed -$606K 225
2013
Q4
$606K Buy
7,168
+154
+2% +$12.2K 0.02% 142
2013
Q3
$541K Sell
7,014
-136
-2% -$9.53K 0.03% 140
2013
Q2
$418K Buy
+7,150
New +$430K 0.02% 148

Other funds holding CELG

Churchill Management's CELG Position: Q4 2017 in Review

Churchill Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 47,770 shares — an estimated $6.97M sold.

Churchill Management first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $6.97M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Churchill Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Churchill Management sold 47,770 Celgene Corp shares in Q4 2017, an estimated $6.97M.
  • Churchill Management first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • Churchill Management's Celgene Corp position peaked at $6.97M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Churchill Management's 13F filing for Q4 2017, filed 11 Jan 2018.